Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in Eosinophilic Esophagitis
NCT01808196Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Oct 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of losartan in eosinophilic esophagitis (EoE), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Percent of Participants in Histologic Remission at 16 weeks. Started Oct 2013; status: completed.
02
Drugs
losartan
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT01808196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808196.